HHS Spends $90 Million On Bioterror Treatments

Luke 21:7 “Teacher,” they asked, “when will all this happen? What sign will show us that these things are about to take place?” Luke 21:11 "There will be great earthquakes, and there will be famines and epidemics in many lands, and there will be terrifying things (that which strikes terror), and great miraculous signs in the heavens."

The Department of Health and Human Services will spend $90 million over the next five years for a drug that can help stop two bacteria which security officials believe could make a deadly bioterror weapon.

HHS officials have already released $19.8 million for the purchase of Caravance, a drug that is aimed as a countermeasure to melioidosis and glanders diseases.

According to a press release from HHS, both glanders and melioidosis are considered suitable for biological weapons.  Untreated infections from the diseases have a mortality rate of 90%.   The bacteria have also developed some resistance to current antibiotics meaning even if you are treated for an infection there is still a 40% mortality rate.

Glanders is a respiratory disease transmitted either airborne or when the victim comes in contact with contaminated animals.   Melioidosis, which is often confused for other conditions like pneumonia, is also transmitted through air or contact.

Leave a Reply